Long-term survival of central visual field in end-stage glaucoma.
OBJECTIVE
To evaluate the long-term survival of visual field and visual acuity in treated glaucoma patients with end-stage glaucomatous visual field loss defined by a field constricted to a 10-degree radius or less.


METHODS
Retrospective chart review.


METHODS
Sixty-four patients with end-stage glaucoma.


METHODS
Serial 10-2 Humphrey visual fields with size III stimulus were analyzed. The following data were recorded for each visual field: mean deviation (MD), pattern standard deviation, the largest horizontal and vertical diameters measured in degrees including only locations with thresholds of 10 decibels or more, and the number of points on the pattern deviation plot with a probability value of more than 5%.


METHODS
Change in visual acuity and visual field.


RESULTS
Eighty-four eyes of 64 patients satisfied inclusion criteria with an average follow-up of 8.34+/-3.1 years. Seventy-eight percent of patients were black. During the study period, 14 eyes lost more than 3 lines of visual acuity. Of these 14, 8 eyes progressed to a visual acuity of 20/200 or worse. Seven eyes lost 3 decibels or more from the MD that could be reproduced over 2 visual fields.


CONCLUSIONS
In this predominantly black population, most treated patients with end-stage glaucoma did not demonstrate a decline in visual acuity or progressive loss of the central visual field during long-term follow-up.
Much
Jason W
JW
Department of Ophthalmology, University of Virginia, Charlottesville, Virginia 22908, USA. jwm7e@virginia.edu
Liu
Chengcheng
C
Piltz-Seymour
Jody R
JR
D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D015812:Glaucoma, Angle-Closure / Q000503:physiopathology*; D005902:Glaucoma, Open-Angle / Q000503:physiopathology*; D006801:Humans; D007429:Intraocular Pressure / Q000502:physiology; D008297:Male; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D014065:Tonometry, Ocular; D014786:Vision Disorders / Q000503:physiopathology*; D014792:Visual Acuity / Q000502:physiology*; D014794:Visual Fields / Q000502:physiology*